BioSpace News Archive

- Allena Pharmaceuticals, Inc. (NASDAQ:ALNA), a late-stage, biopharmaceutical company dedicated to developing and commercializing first-in-class, oral enzyme therapeutics to treat patients with rare and severe metabolic and kidney disorders, today announced that it has entered into a $25 million convertible debt financing a

electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine company, today announced that the Department of Veterans Affairs has agreed to sponsor a quadruple blind, randomized, sham-controlled clinical trial of non-invasive vagal nerve stimulation (nVNS) in mild traumatic brain injury (mTBI) and Post-Traumatic Stress Disorder (PTSD). The trial is being sponsored by the Department of Veterans Affairs (VA) Office of Researc

Collegium Pharmaceutical, Inc. (Nasdaq: COLL), a specialty pharmaceutical company committed to being the leader in responsible pain management, today announced that it has reached a settlement agreement with Teva Pharmaceutical USA, Inc. (Teva) that resolves patent litigation brought in response to Teva’s Abbreviated New Drug Application (ANDA), seeking approval to market a generic version of Xtampza ER prior to the expiration of Collegium

Harrow Health, Inc. announced the appointment of Larry Van Horn to its Board of Directors.

Tabula Rasa HealthCare, Inc (TRHC) (NASDAQ: TRHC), a healthcare technology company advancing the field of medication safety, announced a partnership with Direct Scripts , a pharmacy solutions administrator focused on benefits management for self-insured employers. “We have forged a strategic partnership with Direct Scripts which will enable us to expand our Medication Therapy Management and MedWise™ medication safety review services to

Emerging health threats, uncured diseases and the need to deliver critical therapies to patients are driving biotech companies to search for ways to build flexibility into their complex product pipelines and deliver projects in record time.

Allergan Aesthetics, an AbbVie company, announced the launch of SkinMedica® TNS® Advanced+ Pro-Infusion Serum for DiamondGlow™ treatments.

Vexos Inc., a Global Electronics Manufacturing Services provider, is pleased to announce that Health Canada has approved the Mechanical Ventilator Milano (MVM) ventilator for use under Interim Order. In May, Vexos signed a contract with the Government of Canada to manufacture and supply 10,000 MVM units as part of the national mobi

I-Mab (the “Company”) (Nasdaq: IMAB), a clinical stage biopharmaceutical company committed to the discovery, development and commercialization of novel biologics, today

PulsePoint, a technology company using real-time data to accelerate health outcomes, today announced the launch of its Health Marketplace, the largest turnkey and always-on publisher ecosystem that provides health marketers, via its programmatic media platform, Life by PulsePoint™,